Meet our teamTeam
Initial Public Offering (IPO) on the Warsaw Stock Exchange (WSE)IPO
Funding Milestones - From Seed to Growth
BrainScan has secured multiple rounds of funding, including a recent €2.5 million grant from the Polish Agency for Enterprise Development (PARP) to support the development of its multimodal diagnostic platform. In May 2024, BrainScan CT became a publicly traded company on the Warsaw Stock Exchange’s NewConnect market under the ticker symbol BSN.
historyCompany History and Strategic Plans
In 2025, BrainScan targets FDA certification and U.S. patent approval, enabling entry into the American medical market and reinforcing its innovation leadership. The company also continues scientific research in collaboration with the Provincial Hospital in Poznan and LMU Hospital in Munich. These partnerships support clinical validation and help refine upcoming features, including automated report generation planned for 2026 to streamline radiologists' workflows.
In 2024, BrainScan expanded its AI capabilities to detect 30 key brain pathologies, making it one of the most comprehensive tools in neuroimaging. The company also completed its first full on-premise installation, offering hospitals full data control and local AI-powered diagnostics.
In 2023, BrainScan completed its first implementation in a European hospital outside Poland. That same year, the company received CE MDR 2017/745 certification, enabling full compliance with updated EU medical device regulations.
Between 2018 and 2021, BrainScan received CE certification for its AI-powered diagnostic system. The company also won the Gold Medal at RSNA in the U.S., confirming its global innovation leadership in radiology AI solutions.
BrainScan was founded in 2017 to revolutionize brain CT diagnostics using AI. The company began developing its own deep learning system for detecting critical brain pathologies in CT scans, setting the foundation for future clinical use and certification.
Thanks to the BrainScan AI tool, we’ve seen a clear reduction in patient stay times in the emergency department, especially for those with intracranial hemorrhages. The time from CT scan to consultation and transfer to neurosurgery has been significantly shortened.
The system instantly alerts ER physicians if bleeding is detected, allowing immediate decisions without waiting for a radiologist’s report. This fast-tracks treatment in critical cases and improves patient survival outcomes.

Just a few days ago, a woman in her 40s–50s arrived at our Emergency Department complaining of a severe headache. A head CT scan was performed immediately. Thanks to the BrainScan AI software, a subtle and difficult-to-detect subarachnoid hemorrhage near the skull was identified within seconds.
This early detection enabled rapid consultation and transfer to the neurosurgical unit, where emergency brain surgery was performed without delay. There is no doubt – the AI alert system helped save the patient’s life by significantly reducing time to treatment in a critical condition.

testimonialsHear what our customers say about our AI solutions
get in touchWe are always ready to help you and answer your questions
BrainScan SA
office:
ul. Kieturakisa 10
80-742 Gdansk
Poland
VAT-ID: PL5862321880
Email:
BrainScan SA
software development center:
ul. Traugutta 75
80-221 Gdansk
Poland








